• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. NC TREK; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. NC TREK; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 1012455-15
Medical Device Problem Code Difficult to Remove (1528)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/20/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event or Problem Description
It was reported that the procedure was performed to treat a heavily calcified lesion in the right coronary artery.After non-abbott stents were deployed at the target lesion, post dilatation was performed using a 5x15mm nc trek rx balloon dilatation catheter (bdc).It was noted however, after dilatation and deflation the bdc was not able to be removed, and the bdc was removed along with the guiding catheter as a single unit.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Event or Problem Description
It was reported that the procedure was performed to treat a heavily calcified and mildly tortuous lesion in the right coronary artery.After non-abbott stents were deployed at the target lesion, post dilatation was performed using a 5x15mm nc trek rx balloon dilatation catheter (bdc).It was noted after dilatation and deflation the bdc was difficult to be removed from the stent, however, the bdc was ultimately removed along with the 6f guiding catheter as a single unit.No further treatment was needed so the procedure was completed.There were no adverse patient effects and no clinically significant delay in the procedure.Subsequent to filing the initial report, returned device analysis revealed that the inner and outer member of the bdc were separated and torn.The account was not aware of the separation or tears.No additional information was provided.
 
Additional Manufacturer Narrative
A visual inspection was performed on the returned device.The reported difficulty to remove could not be replicated in a testing environment as it was based on operational circumstances.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a review of the complaint history identified no other similar complaints from this lot.Based on the reported information and the observations from the returned device analysis, a definitive cause for the reported difficulty removing the device could not be determined.Returned device analysis noted that the distal shoulder area of the balloon was folded into itself, and the balloon was wrinkled across the length of the balloon.In this case, it is possible that since this is a larger balloon profile, sufficient time was not allowed to fully deflate the balloon before an attempt was made to withdraw the device resulting in the noted damage to the balloon and interaction with the stent which subsequently resulted in the reported difficulty removing the device from the stent; however, a conclusive cause cannot be determined.Based on the results of the complaint investigation there is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC TREK
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR COSTA RICA, REG # 3009564766
52 calle 3 b31 coyol free zone
el coyol alajuela
CS  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key20440554
Report Number2024168-2024-12076
Device Sequence Number20873917
Product Code LOX
UDI-Device Identifier08717648152153
UDI-Public(01)08717648152153(17)260228(10)30308G1
Combination Product (Y/N)N
Initial Reporter CountrySZ
PMA/510(K) Number
K110134
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2026
Device Model Number1012455-15
Device Catalogue Number1012455-15
Device Lot Number30308G1
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 09/23/2024
Supplement Date Received by Manufacturer11/05/2024
Initial Report FDA Received Date10/14/2024
Supplement Report FDA Received Date11/26/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/08/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
4.MM AND 4.5MM ONYX (MEDTRONIC); GUIDING CATHETER
Patient SexUnknown
-
-